Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CB-01-05-MMX add-on therapy for active left-sided mild to moderate ulcerative colitis
2006-001782-42Phase 2Completed
- Sponsor
- Cosmo Pharmaceuticals
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in autoimmune colitis comparing CB-01-05-MMX add-on arm with Placebo add-on arm (2 arms). Primary endpoint: Clinical remission. Started Aug 2006; status: completed.
02
Drugs
parnaparin sodium
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2006-001782-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001782-42.